Unknown

Dataset Information

0

Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers.


ABSTRACT:

Objectives

The purpose of the present study was to assess and describe the severity of symptoms reported by Covid-19 positive patients who vaped (smoked e-cigarettes) when compared to those who did not vape or smoke at the time of the diagnosis of Covid-19.

Methods

Patients from this study are from a well-characterized patient cohort collected at Mayo Clinic between March 1, 2020 and February 28, 2021; with confirmed COVID-19 diagnosis defined as a positive result on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays from nasopharyngeal swab specimens. Among the 1734 eligible patients, 289 patients reported current vaping. The cohort of vapers (N = 289) was age and gender matched to 1445 covid-19 positive patients who did not vape. The data analyzed included: date of birth, gender, ethnicity, race, marital status, as well as lifestyle history such as vaping and smoking and reported covid-19 symptoms experienced.

Results

A logistic regression analysis was performed separately for each symptom using generalized estimating equations (GEE) with robust variance estimates in order to account for the 1:5 age, sex, and race matched set study design. Patients who vaped and developed Covid-19 infection were more likely to have chest pain or tightness (16% vs 10%, vapers vs non vapers, P = .005), chills (25% vs 19%, vapers vs non vapers, P = .0016), myalgia (39% vs 32%, vapers vs non vapers, P = .004), headaches (49% vs 41% vapers vs non vapers, P = .026), anosmia/dysgeusia (37% vs 30%, vapers vs non vapers, P = .009), nausea/vomiting/abdominal pain (16% vs 10%, vapers vs non vapers, P = .003), diarrhea (16% vs 10%, vapers vs non vapers, P = .004), and non-severe light-headedness (16% vs 9%, vapers vs non vapers, P < .001).

Conclusion

Vapers experience higher frequency of covid-19 related symptoms when compared with age and gender matched non-vapers. Further work should examine the impact vaping has on post-covid symptom experience.

SUBMITTER: McFadden DD 

PROVIDER: S-EPMC8744181 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress
| S-BSST719 | biostudies-other
| S-EPMC7864609 | biostudies-literature
| S-EPMC8584903 | biostudies-literature
| S-EPMC8169236 | biostudies-literature
2023-03-24 | GSE222393 | GEO
| S-BSST563 | biostudies-other
| S-EPMC8222239 | biostudies-literature
2022-04-06 | PXD025125 | Pride